ARANX
Price
$25.38
Change
+$0.14 (+0.55%)
Updated
Jul 3 closing price
Net Assets
1.37B
HASAX
Price
$14.06
Change
+$0.07 (+0.50%)
Updated
Jul 3 closing price
Net Assets
769.86M
Interact to see
Advertisement

ARANX vs HASAX

Header iconARANX vs HASAX Comparison
Open Charts ARANX vs HASAXBanner chart's image
Horizon Active Risk Assist® Investor
Price$25.38
Change+$0.14 (+0.55%)
VolumeN/A
Net Assets1.37B
Horizon Active Asset Allocation A
Price$14.06
Change+$0.07 (+0.50%)
VolumeN/A
Net Assets769.86M
ARANX vs HASAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARANX vs. HASAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARANX is a Buy and HASAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARANX has more cash in the bank: 1.37B vs. HASAX (770M). HASAX (0.53) and ARANX (0.51) have matching dividends . ARANX was incepted earlier than HASAX: ARANX (11 years) vs HASAX (10 years). HASAX (1.49) is less costly to investors than ARANX (1.28). HASAX is a more actively managed with annual turnover of: 198.00 vs. ARANX (66.00). ARANX (2500) and HASAX (2500) have matching initial minimum investment requirements. ARANX annual gain was more profitable for investors over the last year : -2.80 vs. HASAX (-8.49). ARANX return over 5 years is better than : 39.28 vs. HASAX (21.13).
ARANXHASAXARANX / HASAX
Total Expense Ratio1.281.4986%
Annual Report Gross Expense Ratio1.281.4986%
Fund Existence11 years10 years-
Gain YTD5.6626.59686%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B770M178%
Annual Yield % from dividends0.510.5396%
Returns for 1 year-2.80-8.4933%
Returns for 3 years23.5318.05130%
Returns for 5 years39.2821.13186%
Returns for 10 years33.96N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.600.11
+7.38%
Pacific Biosciences of California
CIO5.600.10
+1.82%
City Office Reit
PCVX33.25-0.02
-0.06%
Vaxcyte
IQV164.24-0.41
-0.25%
IQVIA Holdings
RVPH0.36-0.02
-6.49%
Reviva Pharmaceuticals Holdings